BACKGROUND AND OBJECTIVES
Response to pre-transplant salvage chemotherapy remains the most important prognostic factor for outcome in refractory or relapsed Hodgkin's lymphoma. Results of a new induction regimen are reported in terms of response rates, toxicity, and stem cell mobilization.
DESIGN AND METHODS
Ninety-one patients with refractory or relapsed… CONTINUE READING